Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

This buy gives Vertex both a recently-commercialized drug, and a very strong lead candidate.

CryptoAlerta — análise de criptomoedas e mercado em tempo real